FibroBiologics Inc (NASDAQ: FBLG) on Tuesday, soared 8.92% from the previous trading day, before settling in for the closing price of $0.64. Within the past 52 weeks, FBLG’s price has moved between $0.58 and $5.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of -37.25%. With a float of $27.42 million, this company’s outstanding shares have now reached $37.74 million.
The firm has a total of 13 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
FibroBiologics Inc (FBLG) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of FibroBiologics Inc is 28.35%, while institutional ownership is 16.80%. The most recent insider transaction that took place on May 27 ’25, was worth 16,800. In this transaction Chief Scientific Officer of this company bought 20,000 shares at a rate of $0.84, taking the stock ownership to the 31,250 shares. Before that another transaction happened on Aug 12 ’24, when Company’s Chief Executive Officer bought 8,500 for $1.91, making the entire transaction worth $16,269. This insider now owns 6,056,647 shares in total.
FibroBiologics Inc (FBLG) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -37.25% per share during the next fiscal year.
FibroBiologics Inc (NASDAQ: FBLG) Trading Performance Indicators
FibroBiologics Inc (FBLG) is currently performing well based on its current performance indicators. A quick ratio of 1.14 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.21, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.52 in one year’s time.
Technical Analysis of FibroBiologics Inc (FBLG)
Analysing the last 5-days average volume posted by the [FibroBiologics Inc, FBLG], we can find that recorded value of 0.46 million was better than the volume posted last year of 0.31 million. As of the previous 9 days, the stock’s Stochastic %D was 60.29%.
During the past 100 days, FibroBiologics Inc’s (FBLG) raw stochastic average was set at 12.02%, which indicates a significant decrease from 68.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0544 in the past 14 days, which was lower than the 0.0992 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7892, while its 200-day Moving Average is $1.6590. Now, the first resistance to watch is $0.7296. This is followed by the second major resistance level at $0.7622. The third major resistance level sits at $0.8044. If the price goes on to break the first support level at $0.6548, it is likely to go to the next support level at $0.6126. Should the price break the second support level, the third support level stands at $0.5800.
FibroBiologics Inc (NASDAQ: FBLG) Key Stats
Market capitalization of the company is 26.67 million based on 39,681K outstanding shares. Right now, sales total 0 K and income totals -11,160 K. The company made 0 K in profit during its latest quarter, and -4,970 K in sales during its previous quarter.
